| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6096341 | BAUSCH | Delayed release tablet of bupropion hydrochloride |
Oct, 2018
(5 years ago) | |
Wellbutrin Xl is owned by Bausch.
Wellbutrin Xl contains Bupropion Hydrochloride.
Wellbutrin Xl has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Wellbutrin Xl are:
- US6096341
Wellbutrin Xl was authorised for market use on 28 August, 2003.
Wellbutrin Xl is available in tablet, extended release;oral dosage forms.
The generics of Wellbutrin Xl are possible to be released after 30 October, 2018.
Drugs and Companies using BUPROPION HYDROCHLORIDE ingredient
Market Authorisation Date: 28 August, 2003
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of WELLBUTRIN XL before it's drug patent expiration?
More Information on Dosage
WELLBUTRIN XL family patents
